| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/26/2008 | US7417034 Pharmaceutically active uridine esters |
| 08/26/2008 | US7417033 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 08/26/2008 | US7416885 Proliferation factor is obtained from the UCHT1 rat thyroid cell line, or a fragment, analogue or derivateve |
| 08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 08/26/2008 | US7416848 DNA encoding SNORF25 receptor |
| 08/26/2008 | US7416730 Derivatives of the IL-2 receptor gamma chain, their production and use |
| 08/26/2008 | CA2441535C Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2392165C Vitamin d analogues |
| 08/26/2008 | CA2361614C Compositions for treating inflammatory response |
| 08/26/2008 | CA2347474C Bicyclic nitrogen heterocycles |
| 08/26/2008 | CA2292638C Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps |
| 08/26/2008 | CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase |
| 08/26/2008 | CA2274773C Aqueous therapeutic agents of ibuprofen |
| 08/26/2008 | CA2208981C Novel trienoic retinoid compounds and methods |
| 08/26/2008 | CA2160779C Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 08/21/2008 | WO2008100628A2 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases |
| 08/21/2008 | WO2008100622A2 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | WO2008100620A2 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | WO2008100618A2 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | WO2008100480A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | WO2008100463A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 08/21/2008 | WO2008100453A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
| 08/21/2008 | WO2008099928A1 Placental protein having action of regulating protease activity and its related gene |
| 08/21/2008 | WO2008099913A1 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient |
| 08/21/2008 | WO2008099906A1 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery |
| 08/21/2008 | WO2008099139A1 1,5-diaryl-pyrazoles as cannabinoid receptor neutral antagonists useful as therapeutic agents |
| 08/21/2008 | WO2008099075A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors |
| 08/21/2008 | WO2008099074A1 Phenyl- (4-phenyl-pyrimidin-2-yl) - amine derivatives as ikk inhibitors, preparation thereof, and pharmaceutical compositions thereof |
| 08/21/2008 | WO2008099073A1 N, n' -2, 4-dianilinopyrimidines preparation and use thereof as ikk inhibitors preparation and teh pharmacuetical compositions thereof |
| 08/21/2008 | WO2008098957A1 Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases |
| 08/21/2008 | WO2008098871A2 Use of chitosans for the treatment of nail inflammatory diseases |
| 08/21/2008 | WO2008098798A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents |
| 08/21/2008 | WO2008098377A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
| 08/21/2008 | WO2008098355A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 08/21/2008 | WO2008075184A3 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them |
| 08/21/2008 | WO2008057855A3 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity |
| 08/21/2008 | WO2008055146A9 Formulations of phospholipase enzyme inhibitors |
| 08/21/2008 | WO2008045558A3 Benzothiadiazine compounds and their use |
| 08/21/2008 | WO2007145922A3 Benzazepinones as sodium channel blockers |
| 08/21/2008 | US20080200646 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin) |
| 08/21/2008 | US20080200547 Highly Purified Ethyl EPA and Other EPA Derivatives |
| 08/21/2008 | US20080200538 Inhibition of Monocyte Survival, Differentiation, or Proliferation |
| 08/21/2008 | US20080200526 N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine, 4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine; allergic rhinitis, asthma, allergic conjunctivitis, allergic dermatitis, atopic dermatitis, contact dermatitis and urticaria |
| 08/21/2008 | US20080200524 Treating pain, inflammation and traumatic injury; using 2-pyridinyl-phenyl-4-amido-p-sulfono or sulfonamidobenzene derivatives |
| 08/21/2008 | US20080200519 5-Amino-1-(4-fluorophenyl)-N-[6-fluoro-1,2,3,4-tetrahydro-2-hydroxy-5-methoxy-4,4-dimethyl-2-(trifluoromethyl)naphthalene-1-yl]-1H-pyrazole-4-carboxamide; selectivity to glucocorticoid receptor; fewer side effect; inhibit secretion of cytokine IL-8 into monocyte cell line THP-1 triggered by lipopolysacch |
| 08/21/2008 | US20080200454 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | US20080200443 Zinc complexes of natural amino acids for treating elevated copper caused toxicities |
| 08/21/2008 | US20080200407 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 08/21/2008 | US20080200403 Semi-synthetic 9a-carbamoyl or thiocarbamoyl azalides; use of 15-membered azalides having at the 9a-position a carbamoyl or thiocarbamoyl group; inhibitor of TNF- alpha , IL-1, IL-6, IL-8, IL-2 or IL-5; and inhibitor of excessive lymphocyte proliferation; and excessive granulocyte degranulation |
| 08/21/2008 | US20080200398 Compounds For Enzyme Inhibition |
| 08/21/2008 | US20080200377 Polyamideesters comprised of dicarboxylic acid and reaction product of diol and amino acid; drug delivery through blood vessels; controlled release, reduced adverse effects, inactivation protection, intracellular penetration enhanced pharmacological activity |
| 08/21/2008 | US20080199865 Using allelic variation in interleukin-1RN variable number of tandem repeats as diagnostic/prognostic indicator of decrease cell division and aging characteristics |
| 08/21/2008 | US20080199543 Pharmaceutically Active Extracts of Vitex Leucoxylon, a Process of Extracting the Same and a Method of Treating Diabetes and Inflammatory Diseases Therewith |
| 08/21/2008 | US20080199460 Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease |
| 08/21/2008 | US20080199445 Compositions and methods for treatment of microbial infections |
| 08/21/2008 | US20080199435 IL-8 Like Protein |
| 08/21/2008 | US20080199414 Tiliroside or derivative; drugs, foods; ultraviolet radiation filters; aging and oxidation resistance; free radical scavengers; antiinflammatory, anticarcinogenic, and antiallergen agents; plant extracts; topically applied |
| 08/21/2008 | DE102007007318A1 Coating composition for bioactive textile materials, useful e.g. for producing wound dressings, comprises layer-forming inorganic nanoparticulate sol and active component, e.g. natural oil |
| 08/21/2008 | CA2679849A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2678436A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
| 08/21/2008 | CA2678072A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2678036A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2677747A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
| 08/21/2008 | CA2677678A1 3,4-dihydro-1,4-benzoxazine, 3, 4-dihydro-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2677649A1 Bioavailable formulations of heterocyclic compounds |
| 08/21/2008 | CA2677588A1 Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases |
| 08/21/2008 | CA2676259A1 Use of chitosans for the treatment of nail inflammatory diseases |
| 08/21/2008 | CA2673534A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors |
| 08/21/2008 | CA2673532A1 New phenyl-(4-phenyl-pyrimidin-2-yl)-amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 08/21/2008 | CA2672959A1 New n, n'- 2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors |
| 08/21/2008 | CA2672955A1 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 08/20/2008 | EP1959013A1 Human circulating virus inhibitory peptide (VRIP) and its use |
| 08/20/2008 | EP1958934A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents |
| 08/20/2008 | EP1958641A1 Treatment and prevention of inflammation |
| 08/20/2008 | EP1958639A1 Use of chitosans for the treatment of nail inflammatory diseases |
| 08/20/2008 | EP1958632A1 Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases |
| 08/20/2008 | EP1958629A1 A transdermal fluid comprising tocotrienol |
| 08/20/2008 | EP1957537A2 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 08/20/2008 | EP1957496A2 Bicyclic protein kinase inhibitors |
| 08/20/2008 | EP1957491A2 Pyrrolo (2,3-b) pyridine derivatives useful as tec kinase inhibitors |
| 08/20/2008 | EP1957486A1 Compositions and methods for modulating gated ion channels |
| 08/20/2008 | EP1957483A1 Novel vinylogous acids derivatives |
| 08/20/2008 | EP1957477A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 08/20/2008 | EP1957107A2 Treating inflammatory disorders with antibodies to the alpha-7 nicotinic receptors |
| 08/20/2008 | EP1957085A2 Macrolides as anti-inflammatory agents |
| 08/20/2008 | EP1896077A4 Methods and compositions for the prevention and treatement of inflammatory disease |
| 08/20/2008 | EP1778632B1 Indoles useful in the treatment of inflammation |
| 08/20/2008 | EP1660492B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/20/2008 | EP1556488B1 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 08/20/2008 | EP1539731B9 Novel compounds |
| 08/20/2008 | EP1509618B1 Autoimmune conditions and nadph oxidase defects |
| 08/20/2008 | EP1509223B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/20/2008 | EP1451202B1 Aryl fused azapolycyclic compounds |
| 08/20/2008 | EP1446500B1 A method for regulating immune function in primates using the foxp3 protein |
| 08/20/2008 | EP1375489B1 Medicinal composition containing 1,3-thiazine derivative |
| 08/20/2008 | EP1318993B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
| 08/20/2008 | EP1075493B1 Dna encoding snorf25 receptor |